The development of medical technology in the last years of the 20th century has been very dynamic. Synthetic single-use products, artificial joint replacements, pacemaker technologies or minimal-invasive procedures result in a high standard of medical care. But despite of the huge progress in this field, we are presumably only at the beginning of a medical technology revolution. The 1st version of the German Medizinproduktegesetz (MPG, Medical Devices Act) came into effect on January 1, 1995. It represents the national implementation of the European directives 90/385/EEC for active implantable medical device, 93/42/EEC for medical devices and 98/79/EEC for in vitro diagnostic devices. With the implementation of this act in the EU internal market, the free movement of medical devices was established. Medical devices that are marketable in one member state of the EU are also marketable in the other EU countries. Manufacturers of medical devices can therefore place their products on the whole EU market. The CEmark on the products is the proof of complying with the essential requirements. The Medical Devices Act guarantees the efficacy and safety of the medical device because the product has to undergo comprehensive control procedures during the design and manufacturing process. The CEmark is a cachet for quality and efficacy. After the market access, the authorities take care of the safety for users and consumers via definition of essential requirements. This book presents the major aspects of the Medical Devices Act and the European directives. Moreover, the responsibilities and duties of a medical device manufacturer are explained as well as the product classifications and what the manufacturer has to keep in mind when designing and producing medical devices that comply with the legal requirements. A lot of physicians implant medical devices without being aware of the highly complex registration landscape. Especially in clinical research, the regulations regarding the use of medical devices should be known. The requirements of the ethics committee and of the legal departments of hospitals are getting more complex and therefore especially the scientist should get acquainted with this topic.

Ph.D., biologist and chemist by education, has more than 18 years of experience in the field of medical devices as well as in the field of national and international medical device legislation - at Allergan Medical Optics (AMO) and Abbott Medical Optics. As "Manager Regulatory Affairs EMEA" at AMO she was responsible for several years for the registration process of all medical devices for AMO´s "Emerging Markets". Moreover, she has been an active member in several working groups of EUCOMED, MECOMED and EUROMCONTACT, which contributed to her overall understanding and expertise in this field. Sibylle offers more than 22 years of experience in the ophthalmic medical device industry which resulted in high expertise and thorough understanding of developments, processes and future trends.